Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
about
A case for immunosuppression for myoblast transplantation in duchenne muscular dystrophy.Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.Calcineurin inhibitors may be a reasonable alternative to cyclophosphamide in the induction treatment of active lupus nephritis: A systematic review and meta-analysis.Lupus nephritis: an overview of recent findings.The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria.Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.Update on emerging drug therapies for systemic lupus erythematosus.Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.Recent advances in the treatment of lupus nephritis.Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.Recent progress in the treatment of lupus nephritis.NFAT gene family in inflammation and cancer.Diagnosis and treatment of lupus nephritis flares--an update.Overview of lupus nephritis management guidelines and perspective from Asia.Treatment of young patients with lupus nephritis using calcineurin inhibitors.Overview of lupus nephritis management guidelines and perspective from Asia.Treatment of lupus nephritis: practical issues in Asian countries.Treatment of severe lupus nephritis: the new horizon.Mycophenolate mofetil for lupus nephritis: an update.Towards new avenues in the management of lupus glomerulonephritis.Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis.Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.Tacrolimus (FK506): Safety and Applications in Reconstructive Surgery.Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.[Established medications : new areas of application].Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.The efficacy of add-on tacrolimus for minor flare in patients with systemic lupus erythematosus: a retrospective study.Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis.Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.Glomerular Disease in Women.Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus
P2860
Q33713776-E8098ACD-EEE8-4D07-A2A6-8F54353A4143Q33960223-2CCDD048-9DE5-4FC0-A8C2-B6B2C35373FEQ35187502-500A7673-8FFD-478A-BBA0-85F4E9A0CE0CQ35867038-F6273A3A-AC09-4536-AD41-DE030E618213Q35897121-A8CCBCEB-05EB-4FC7-BF3A-CDDC8A59CF43Q36338094-30894C5B-FF02-42CC-BC3E-DF7A931C0E8BQ37150681-E6180E0B-EAAF-4E86-907E-8A2EE4DA2A4FQ37541561-32535D9A-E321-494C-BEB0-17E98E87E216Q37690745-74F5AD8C-6625-4DC8-AC85-8CA6211B9068Q37850608-D4392345-51E3-4C48-8A50-572FB7492969Q37953243-0831C7D1-D2BF-4C84-8988-538CAC351F27Q37954539-D0447173-3529-4CEA-AC4C-922EF38D71DFQ38010014-4B6D045E-4C88-4680-841B-E2D2F5CA1604Q38040813-AD8270A7-3D18-41B6-B503-A33A18EF91ECQ38059445-17297D20-1768-481D-B49B-CFD869DCDE6CQ38123242-000B9DCB-E667-48E3-AA40-3A978A0EC318Q38156915-B8F2DA5B-B78D-4C96-80FF-E62E1D49F8BDQ38175076-9DBC8FAD-6CC7-49F7-AAE7-DC2636328550Q38223302-0FC049F8-39F5-4780-89CB-E9FB79E07E79Q38271125-2975A9A0-16DA-420C-AE7B-3440802B8669Q38585887-45767B4E-963B-40BB-AEA4-6BE062DE54BDQ38686467-0109C0EE-2C26-4922-9DA3-172BEEF3497CQ38976307-B8C828BC-80DB-49C0-9A5D-E890F81E4BB3Q39425964-7615B620-6C64-4CF6-8F3F-ED82966EEE18Q42056355-4774132E-A773-4CF6-BF48-11F1828EC4BDQ43004356-50E0F061-4009-4A5D-94B9-8046E3B6357DQ43031095-8D17213F-2AB0-4D96-B2DA-5D4384C7D322Q44480906-202D884A-C82A-425F-8970-8768CB33E76FQ46119727-E79F2B86-75ED-4881-8919-148729AB027FQ47707507-C2763AC5-605F-4D4A-845E-B1EE4FDBF2E2Q50438118-D72B69F0-2F36-48B1-97C3-5A142964EEDBQ50513436-A98C21DB-454C-4ECA-AF74-385EAD178708Q53161789-363266A6-BB5E-4091-89FF-2E017BB84455Q53649024-64ED9A5C-C575-4057-BBC2-41F1CA9A5B63Q54994281-56DE1EFA-45D7-4989-8A74-990FB9BFA757Q58204824-81CB0AF9-3C9D-45E4-9720-05AB0E8C437F
P2860
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
@en
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
@nl
type
label
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
@en
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
@nl
prefLabel
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
@en
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis
@en
P2093
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEN335
P577
2008-08-27T00:00:00Z